Home > Cashflow Statement > PIRAMAL PHARMA

PIRAMAL PHARMA
Cash Flow from Financing Activities

    Back to Cashflow Statement
COMMUNITY POLL
for PIRAMAL PHARMA
Please provide your vote to see the results

PIRAMAL PHARMA Last 5 Year Cash Flow from Financing Activities History

[Consolidated]

Mar2026Mar2025Mar2024Mar2023Mar2022
Cash Flow from Financing Activities ₹-39 Cr₹-441 Cr₹-422 Cr₹818 Cr₹794 Cr

What is the latest Cash Flow from Financing Activities ratio of PIRAMAL PHARMA ?

The latest Cash Flow from Financing Activities ratio of PIRAMAL PHARMA is ₹-39 Cr based on Mar2026 Consolidated results.
Year Cash Flow from Financing Activities
Mar2026₹-39 Cr
Mar2025₹-441 Cr
Mar2024₹-422 Cr
Mar2023₹818 Cr
Mar2022₹794 Cr

How is Cash Flow from Financing Activities of PIRAMAL PHARMA Trending?

Years Cash Flow from Financing Activities % Change
Mar2026 ₹-39 Cr
Negative
Mar2025 ₹-441 Cr
Negative
Mar2024 ₹-422 Cr
Negative
Mar2023 ₹818 Cr
2.97
Mar2022 ₹794 Cr -

Compare Cash Flow from Financing Activities of peers of PIRAMAL PHARMA

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
PIRAMAL PHARMA ₹22,865.1 Cr -0.1% 2.7% -14.6% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹468,458.0 Cr 0.7% 8.1% 16% Stock Analytics
DIVIS LABORATORIES ₹193,383.0 Cr 7% 10.2% 3.7% Stock Analytics
TORRENT PHARMACEUTICALS ₹169,829.0 Cr 2.5% 11.3% 49.6% Stock Analytics
CIPLA ₹116,164.0 Cr -0.3% 4.1% -3.3% Stock Analytics
DR REDDYS LABORATORIES ₹102,648.0 Cr -3.2% -3.9% -3% Stock Analytics


PIRAMAL PHARMA Share Price vs Sensex

Share Price Returns(%) 1 Week 1 Month 1 Year
PIRAMAL PHARMA

-0.1%

2.7%

-14.6%

SENSEX

0.9%

2.2%

-7.5%


You may also like the below Video Courses